The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.

Shioya, Akihiro; Guo, Xin; Motono, Nozomu; Mizuguchi, Seiya; Kurose, Nozomu; Nakada, Satoko; Aikawa, Akane; Ikeda, Yoshitaka; Uramoto, Hidetaka; Yamada, Sohsuke

Shioya, Akihiro; Guo, Xin; Motono, Nozomu; Mizuguchi, Seiya; Kurose, Nozomu; Nakada, Satoko; Aikawa, Akane; Ikeda, Yoshitaka; Uramoto, Hidetaka; Yamada, Sohsuke.

Afiliação

Shioya A; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Guo X; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Motono N; Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa.
Mizuguchi S; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.
Kurose N; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Nakada S; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.
Aikawa A; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Ikeda Y; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.
Uramoto H; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Yamada S; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.

Int J Med Sci ; 15(10): 1025-1034, 2018.

Article em En | MEDLINE | ID: mdl-30013444

Assuntos

Adenocarcinoma de Pulmão/genética; Adenocarcinoma/genética; Neoplasias Pulmonares/genética; Peroxirredoxinas/metabolismo; Adenocarcinoma/mortalidade; Adenocarcinoma/terapia; Adenocarcinoma de Pulmão/mortalidade; Adenocarcinoma de Pulmão/terapia; Adulto; Idoso; Idoso de 80 Anos ou mais; Anticorpos Antinucleares; Anticorpos Monoclonais; Intervalo Livre de Doença; Feminino; Humanos; Japão; Neoplasias Pulmonares/mortalidade; Neoplasias Pulmonares/terapia; Masculino; Pessoa de Meia-Idade; Recidiva Local de Neoplasia; Estresse Oxidativo; Prognóstico; Estudos Retrospectivos

Palavras-chave

MIB-1; PRDX4; lung adenocarcinoma (LUAD); recurrence.; stage I

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Peroxirredoxinas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google